This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Tvardi Therapeutics, Inc., Tvardi Operating Company, Inc.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Imran Alibhai: Innovator in Therapeutic Compounds
Introduction
Imran Alibhai is a notable inventor based in Sugar Land, TX (US). He has made significant contributions to the field of therapeutic compounds, holding a total of 5 patents. His work primarily focuses on developing innovative treatments for various diseases, including cancer and chronic inflammation.
Latest Patents
Among his latest patents are the "Prodrugs of STAT3 inhibitors," which include compounds designed to treat diseases such as cancer, fibrosis, and chronic inflammation. These compounds are presented in various forms, including pharmaceutically acceptable salts and solvates. Another significant patent is related to "Therapeutic compounds, formulations, and uses thereof," which details compositions and dosage forms that incorporate specific ingredients like emulsifiers and antioxidants, aimed at treating similar health issues.
Career Highlights
Imran has worked with prominent companies in the pharmaceutical sector, including Tvardi Therapeutics, Inc. and Tvardi Operating Company, Inc. His expertise in developing therapeutic solutions has positioned him as a key player in the industry.
Collaborations
Throughout his career, Imran has collaborated with talented professionals, including Sofia De Achaval and Beverly C Langevin. These partnerships have contributed to the advancement of his innovative projects.
Conclusion
Imran Alibhai's work in the field of therapeutic compounds showcases his dedication to improving healthcare through innovation. His patents reflect a commitment to addressing critical health challenges, making him a significant figure in the realm of medical inventions.